Pliant Therapeutics (PLRX) Operating Leases (2021 - 2025)
Historic Operating Leases for Pliant Therapeutics (PLRX) over the last 5 years, with Q3 2025 value amounting to $29.4 million.
- Pliant Therapeutics' Operating Leases fell 112.26% to $29.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.4 million, marking a year-over-year decrease of 112.26%. This contributed to the annual value of $29.4 million for FY2024, which is N/A changed from last year.
- Pliant Therapeutics' Operating Leases amounted to $29.4 million in Q3 2025, which was down 112.26% from $30.0 million recorded in Q2 2025.
- In the past 5 years, Pliant Therapeutics' Operating Leases registered a high of $30.1 million during Q2 2024, and its lowest value of $2.3 million during Q2 2023.
- In the last 5 years, Pliant Therapeutics' Operating Leases had a median value of $15.4 million in 2022 and averaged $16.7 million.
- Its Operating Leases has fluctuated over the past 5 years, first tumbled by 6405.64% in 2023, then soared by 119672.13% in 2024.
- Quarter analysis of 5 years shows Pliant Therapeutics' Operating Leases stood at $5.3 million in 2021, then plummeted by 35.61% to $3.4 million in 2022, then crashed by 32.4% to $2.3 million in 2023, then surged by 1170.02% to $29.4 million in 2024, then fell by 0.07% to $29.4 million in 2025.
- Its Operating Leases was $29.4 million in Q3 2025, compared to $30.0 million in Q2 2025 and $29.9 million in Q1 2025.